PIM1 and pancreatic neoplasm: In addition, plasma levels of PIM-1 in patients with pancreatic cancer were significantly higher than were those in all control subjects combined (29.8 ± 47.7 ng/ml vs. 7.21 ± 8.3 ng/ml, P = 0.000) (Fig. 5c).